These results indicate that celastrol treatment to macrophages suppresses the stimulatory effects of macrophages on cancer migration and invasion, possibly mediated through the inhibition of NLRP3 inflammasome activation and the consequent reduction of IL-1β secretion. This evidence concerns the gene NLRP3 and cancer.